Daraus:
Astragaloside IV (AS-IV), a small molecular saponin purified from Astragalus membranaceus , is the main active ingredient and is well-known for its multiple peripheral pharmacological effects and central nervous system neuroprotective effects, with evidences in animal models indicating its therapeutic potential for AD and Parkinson’s disease.
AS-IV can improve behavioral and neurochemical deficits largely due to its antioxidant, antiapoptotic and anti-inflammatory properties.
AS-IV enhances stroke patients’ recovery from their neurological disability and improves functional outcome.